CAR-M technology: A novel approach to overcome CAR-T limitations in solid tumor treatment

by

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric Antigen Receptor T-cell) treatments. The work is published in the journal Biomarker Research.

Leave A Comment

Your email address will not be published. Required fields are marked *